8 Followers on Owler
OverviewCompetitorsAcquisitionsFundingNews & Insights

Polaris Competitors or Alternatives

Polaris's top competitors include PNP Therapeutics, Monopar and Apexian Pharmaceuticals.

Unlock 12 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Polaris's company profile

Steve J.P. Hsu

CEO

- -
25 - 100
$100.3M
$5M - 25M
  • $100.3M
    $5M - 25M
  • 25 - 100
    $100.3M
  • $5M - 25M
  • - -
  • 25 - 100
  • $100.3M
  • $5M - 25M
View ProfileView
1
Polaris's Competitor - PNP Therapeutics logo

James F. Fuqua

President

90/100
25 - 100
$2.7M
$5M - 25M
  • $2.7M
    $5M - 25M
  • 25 - 100
    $2.7M
  • $5M - 25M
  • 90/100
  • 25 - 100
  • $2.7M
  • $5M - 25M
View ProfileView
2
Polaris's Competitor - Monopar logo

Chandler D. Robinson

Co-Founder & CEO

90/100
10
$39.9M
  • $39.9M
  • 10
    $39.9M
  • 90/100
  • 10
  • $39.9M
View ProfileView
3
Polaris's Competitor - Apexian Pharmaceuticals logo

David Broecker

Interim-CEO

90/100
25 - 100
$7.7M
$5M - 25M
  • $7.7M
    $5M - 25M
  • 25 - 100
    $7.7M
  • $5M - 25M
  • 90/100
  • 25 - 100
  • $7.7M
  • $5M - 25M
View ProfileView
4
Polaris's Competitor - Rexahn logo

Douglas J. Swirsky

President & CEO

86/100
18
$141.4M
$5.7M
  • $141.4M
    $5.7M
  • 18
    $141.4M
  • $5.7M
  • 86/100
  • 18
  • $141.4M
  • $5.7M
View ProfileView
5
Polaris's Competitor - Biotest logo

Michael Ramroth

Chairman

90/100
2,426
- -
$786.3M
  • - -
    $786.3M
  • 2,426
    - -
  • $786.3M
  • 90/100
  • 2,426
  • - -
  • $786.3M
View ProfileView
Polaris' top 15 competitors are PNP Therapeutics, Monopar, Apexian Pharmaceuticals, Silverback Therapeutics, Rexahn, Biotest, Inhibrx, Humanetics, Phanes, Cantex Pharmaceuticals, Inc., bluebird bio, NexImmune, Evgen Pharma, OncBioMune and Daiichi Sankyo. Together they have raised over 2.6B between their estimated 22.1K employees. Polaris's revenue is the ranked 7th among it's top 10 competitors. The top 10 competitors average 886.7M. Polaris has 35 employees and is ranked 7th among it's top 10 competitors. The top 10 competitors average 1,382.

Polaris VS PNP Therapeutics

PNP Therapeutics is seen as one of Polaris's biggest rivals. PNP Therapeutics is headquartered in Birmingham, Alabama, and was founded in 2000. Like Polaris, PNP Therapeutics also works within the Biotechnology sector. PNP Therapeutics generates 128% the revenue of Polaris.

Polaris VS Monopar

Monopar is seen as one of Polaris's top competitors. Monopar was founded in 2014, and its headquarters is in Wilmette, Illinois. Monopar operates in the Biotechnology industry. Monopar has 25 fewer employees than Polaris.

Polaris VS Apexian Pharmaceuticals

Apexian Pharmaceuticals is one of Polaris's top rivals. Apexian Pharmaceuticals is a Private company that was founded in Indianapolis, Indiana in 2007. Apexian Pharmaceuticals operates in the Pharmaceuticals industry. Apexian Pharmaceuticals has 7 fewer employees vs. Polaris.

Looking for similar companies to Polaris?

Similar Companies

Biotechnology companies in San Diego

See 553 companies 
Pharmaceuticals & Biotechnology companies in San Diego

See 720 companies 
Biotechnology companies in San Diego County

See 687 companies 
Pharmaceuticals & Biotechnology companies in San Diego County

See 904 companies 
Biotechnology companies in California

See 3,097 companies 
Biotechnology companies with revenue in $5.0-25M range

See 3,620 companies 
Pharmaceuticals & Biotechnology companies in California

See 4,181 companies 
Biotechnology companies with employees in 25-100 range

See 5,165 companies 
Pharmaceuticals & Biotechnology companies with revenue in $5.0-25M range

See 5,528 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Polaris and Polaris's Competitors

March 31, 2025centralcharts
WILMETTE, Ill., March 31, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on deve...
March 31, 2025centralcharts
EQS-News: Biotest AG / Key word(s): Annual Report Biotest AG increases sales by 6% in financial year 2024 31.03.2025 / 07:00 CET/CEST The issuer is sol...
March 31, 2025Korea Biomedical Review
Daiichi Sankyo Korea has dismissed concerns about Dato-DXd (datopotamab deruxtecan), an antibody-drug conjugate (ADC) being developed as a follow-on to...
March 31, 2025Sharecast
AstraZeneca announced on Monday that it secured a US regulatory approval and a positive EU recommendation for two of its oncology therapies, Imfinzi an...
March 31, 2025centralcharts
EQS-Ad-hoc: Biotest AG / Key word(s): Delisting Biotest AG: Delisting agreement and announced delisting tender offer 31-March-2025 / 08:40 CET/CEST Dis...
March 31, 2025Businessinsider
AstraZeneca's ( AZN ) Imfinzi in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by Imfinzi as adjuvant monotherapy after...

Frequently Asked Questions about Polaris

  1. Who are Polaris's top competitors?

    Polaris's top 3 competitors are PNP Therapeutics, Monopar, Apexian Pharmaceuticals.

  2. Who is similar to Polaris?

    PNP Therapeutics is the most similar to Polaris. Monopar and Apexian Pharmaceuticals are also similar to Polaris.

  1. Are Polaris and PNP Therapeutics competitors?

    Yes, PNP Therapeutics is one of Polaris’s top competitors.